MR

Michael Riccio

Managing Partner- Falcon Partners

Seattle, Washington

Invests in

Stages:

  • Min Investment:

    $25,000.00
  • Max Investment:

    $200,000.00
  • Target Investment:

    $100,000.00

Work Experience

  • Founder and Managing Partner

    2002

    Overall responsibility for the management and operations of the Firm. Most recent investments include: Augmenix (Boston Scientific) National Healing Corp. (Healogics), nLight, Seeq, OTO Nexus Medical Solutions, Confluent Surgical (Covidien), Opanga Networks, Circle Internet Financial, and BitWave.

2003 - 2004

  • Chief Executive Officer and Board Member

    2003 - 2004

    As the first CEO, responsible for creating the business plan and strategy, evaluating financing alternatives, and establishing the product development objectives. Acquired by Microsoft.

2000 - 2001

  • Executive Vice President

    2000 - 2001

    Led the Broadband Division with responsibility for building products and applications targeting the cable TV and high speed Internet markets.

1998 - 2001

  • Chief Operating Officer and Board Member

    1998 - 2001

    Overall responsibility for Go2Net's strategic initiatives, including business development, corporate development, mergers and acquisitions, investments and international business strategy.

1995 - 1998

  • Outside Counsel

    1995 - 1998

    As Lycos' primary outside legal counsel, worked directly with the executive team on equity financings (including the successful IPO and follow-on offering), M&A activities, strategic alliances, investments and global ventures. Having become a publicly traded company just 10 months after it was founded, Lycos holds the distinction of being the youngest company to go public in NASDAQ history.

  • Partner

    1989 - 1998

    Focused on venture capital and private equity, M&A, IPOs and early stage company representation.

  • Corporate Associate

    1986 - 1989

    Focused on M&A, corporate finance and securities transactions. Expertise on poison pills and other anti-takeover measures.